A Hybrid Closed-Loop System Is Cost Effective for Adults With T1D
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cost-Effectiveness Analysis of a Hybrid Closed-Loop System Versus Multiple Daily Injections and Capillary Glucose Testing for Adults With Type 1 Diabetes
Diabetes Technol. Ther. 2020 Nov 01;22(11)812-821, A Pease, E Zomer, D Liew, A Earnest, G Soldatos, Z Ademi, S ZoungasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.